Media Home | Contact Us

Media Relations Links • About Us • Media Contact • Frequently Asked Questions • Media Site Map CDC News • Press Release Library • Transcripts • MMWR Summaries • B-Roll Footage • Upcoming Events Related Links • Centers at CDC • Data and Statistics • Health Topics A-Z • Image Library • Publications, Software and Other Products • Global Health Odyssey Find your state or local health department HHS News National Health Observances Div. of Media Relations 1600 Clifton Road MS D-14 Atlanta, GA 30333 (404) 639-3286 Fax (404) 639-7394

November 21, 2001/11:00 AM, ET Contact: CDC Media Relations (404) 639-3286 Press Release CDC Update: Connecticut Anthrax Case Confirmed, New York Subway Samples Negative; MMWR Notice on Minnesota Knee Surgery Cases Connecticut Inhalation Anthrax Case Confirmed CDC has confirmed a case of inhalational anthrax in Connecticut. CDC was contacted by the Connecticut Department of Public Health about a respiratory illness in a 94-year-old female which preliminary tests had indicated to be anthrax. CDC conducted PCR (polymerase chain reaction) testing on specimens from the woman and confirmed anthrax. In addition to confirming the anthrax case, CDC has sent a team to Connecticut to assist state health department officials. Summary of Local, State, and Federal Confirmed Human Cases and Exposures Case Status Florida New York City New Jersey Washington, DC Connecticut Total Confirmed 2 5 5 5 1 18     Cutaneous 0 4 3 0 0       Inhalational 2 1 2 5 1   Suspect 0 3 2 0   5     Cutaneous 0 3 2 0         Inhalational 0 0 0 0     CDC confirmed cases are based on a rigorous case definition, which was published in CDC’s Morbidity and Mortality Weekly Report (MMWR) on October 19, 2001. The MMWR is available on-line at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5041a1.htm. CDC defines a confirmed case of anthrax as 1) a clinically compatible case of cutaneous, inhalational, or gastrointestinal illness that is laboratory confirmed by isolation of B. anthracis from an affected tissue or site or 2) other laboratory evidence of B. anthracis infection based on at least two supportive laboratory tests. CDC defines a suspect case as 1) a clinically compatible case of illness without isolation of B. anthracis and no alternative diagnosis, but with laboratory evidence of B. anthracis by one supportive laboratory test or 2) a clinically compatible case of anthrax epidemiologically linked to a confirmed environmental exposure, but without corroborative laboratory evidence of B. anthracis infection. Cutaneous anthrax is a boil-like skin lesion that eventually forms an ulcer with a black center or crust (similar in appearance to some spider bites). The cutaneous form of anthrax responds well to antibiotics if treatment is started soon after symptoms appear, such as in this case. Individuals should, especially in areas that have been directly affected, review and be familiar with advice provided to all postal patrons by the US Postal Service and follow that advice. New York City Update Environmental samples taken from subway stations as part of the investigation into the case of inhalation anthrax in New York City have come back negative for anthrax. The samples, taken earlier this month, were sent to CDC for analysis. Environmental tests were conducted in subway stations along the "Number 6" line as part of an investigation into the inhalation anthrax death of a woman who worked at the Manhattan Eye, Ear, and Throat Hospital. No evidence of anthrax has been found in the woman's apartment or in her place of work. MMWR 11-23-01:  This week’s Morbidity and Mortality Weekly Report includes the Notice to Readers: “Unexplained Deaths Following Knee Surgery — Minnesota, November 2001.” The MMWR is available online at www.cdc.gov/mmwr. For the latest update on CDC activities and on-going anthrax investigations visit www.bt.cdc.gov or www.cdc.gov/media.

Media Home Page | Accessibility | Privacy Policy | Contact Us CDC Home | Search | Health Topics A-Z This page last updated November 21, 2001 URL: United States Department of Health and Human Services Centers for Disease Control and Prevention Office of Communication Division of Media Relations